Genetic Signatures Ltd operates in the Electromedical equipment sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Genetic Signatures Ltd with three other
companies in this sector in AUSTRALIA :
Cyclopharm Ltd
(2020
sales of 14.68 million Australian Dollars [US$11.19 million]
of which 99%
was Technegas),
Mach7 Technologies Ltd
(18.86 million Australian Dollars [US$14.38 million]
of which 58%
was Software licenses), and
Nova Eye Medical Ltd
(12.82 million Australian Dollars [US$9.77 million]
of which 90%
was iTrack).
Sales Analysis.
Genetic Signatures Ltd reported sales of A$14.09 million (US$10.74 million)
for the
fiscal
year ending
June of 2020.
This
represents
an
increase of 96.1%
versus 2019, when the company's sales were A$7.18 million.
Sales at Genetic Signatures Ltd have increased during each of the previous five years
(and since 2015, sales have increased a total of 586%).